C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Trouw, Leendert A ^a,e   Okroj, Marcin ^a   Kupreishvili, Koba ^b   Landberg, Göran ^a   Johansson, Bengt ^c   Niessen, Hans W M ^b,d   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; IMMUNOGLOBULIN M; C3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; TISSUE MICROARRAY; ACUTE DISEASE; AORTA VALVE STENOSIS; CADAVER; CARDIOMEGALY; FLOW CYTOMETRY; HEART DISEASE; HEART INFARCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE DISEASE; AORTIC VALVE STENOSIS; CADAVER; CARDIOMEGALY; COMPLEMENT C3; COMPLEMENT C4B-BINDING PROTEIN; FLOW CYTOMETRY; HEART DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 51449108790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002886     Document Type: Article

References (26)

1. Krijnen PA, Nijmeijer R, Meijer CJ, Visser CA, Hack CE, et al. (2002) Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 55: 801-811.
2. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, et al. (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13: 851-856.
3. Entman ML, Michael L, Rossen RD, Dreyer WJ, Anderson DC, et al. (1991) Inflammation in the course of early myocardial ischemia. FASEB J 5: 2529-2537.
4. Rock KL, Hearn A, Chen CJ, Shi Y (2005) Natural endogenous adjuvants. Springer Semin Immunopathol 26: 231-246.
5. Krijnen PA, Meischl C, Nijmeijer R, Visser CA, Hack CE, et al. (2006) Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction? Cardiovasc Hematol Disord Drug Targets 6: 113-123.
6. Mocanu MM, Baxter GF, Yellon DM (2000) Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 130: 197-200.
7. Farb A, Kolodgie FD, Jenkins M, Virmani R (1993) Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. J Am Coll Cardiol 21: 1245-1253.
8. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, et al. (1997) Apoptosis in human acute myocardial infarction. Circulation 95: 320-323.
9. Nijmeijer R, Lagrand WK, Visser CA, Meijer CJ, Niessen HW, et al. (2001) CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? Int Immunopharmacol 1: 403-414.
10. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, et al. (1997) C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95: 97-103.
11. Nijmeijer R, Lagrand WK, Lubbers YT, Visser CA, Meijer CJ, et al. (2003) C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 163: 269-275.
12. Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, et al. (1998) Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 177: 81-87.
13. Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 96: 793-807.
14. Jiang H, Robey FA, Gewurz H (1992) Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J Exp Med 175: 1373-1379.
15. Trouw LA, Bengtsson AA, Gelderman KA, Dahlback B, Sturfelt G, et al. (2007) C4b-binding protein and factor H compensate for the loss of membrane bound complement inhibitors to protect apoptotic cells against excessive complement attack. J Biol Chem 282: 28540-28548.
16. Trouw LA, Nilsson SC, Goncalves I, Landberg G, Blom AM (2005) C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J Exp Med 201: 1937-1948.
17. Webb JH, Blom AM, Dahlback B (2002) Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J Immunol 169: 2580-2586.
18. Webb JH, Blom AM, Dahlback B (2003) The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis dependent. Blood Coagul Fibrinolysis 14: 355-359.
19. Blom AM, Villoutreix BO, Dahlback-B (2004) Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol Immunol 40: 1333-1346.
20. Nijmeijer R, Willemsen M, Meijer CJ, Visser CA, Verheijen RH, et al. (2003) Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death. Am J Physiol Heart Circ Physiol 285: H2218-H2224.
21. Dahlback B (1983) Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 209: 847-856.
22. Krijnen PA, Ciurana C, Cramer T, Hazes T. Meijer CJ, et al. (2005) IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 58: 382-388.
23. Niessen HW, Lagrand WK, Visser CA, Meijer CJ, Hack CE (1999) Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction. Cardiovasc Res 41: 603-610.
24. Oksjoki R, Kovanen PT, Mayranpaa MI, Laine P, Blom AM, et al. (2007) Complement regulation in human atherosclerotic coronary lesions Immunohistochemical evidence that C4b-binding protein negatively regulates the classical complement pathway, and that C5b-9 is formed via the alternative complement pathway. Atherosclerosis 192: 40-48.
25. Oksjoki R, Jarva H, Kovanen PT, Laine P, Meri S, et al. (2003) Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler Thromb Vasc Biol 23: 630-636.
26. Yasojima K, Schwab C, McGeer EG, McGeer PL (2001) Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21: 1214-1219.